These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge. Klas SD; Petrie CR; Warwood SJ; Williams MS; Olds CL; Stenz JP; Cheff AM; Hinchcliffe M; Richardson C; Wimer S Vaccine; 2008 Oct; 26(43):5494-502. PubMed ID: 18703110 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys. Chawla A; Midha S; Bhatnagar R Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443 [TBL] [Abstract][Full Text] [Related]
7. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
8. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores. Chichester JA; Manceva SD; Rhee A; Coffin MV; Musiychuk K; Mett V; Shamloul M; Norikane J; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2013 Mar; 9(3):544-52. PubMed ID: 23324615 [TBL] [Abstract][Full Text] [Related]
9. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328 [TBL] [Abstract][Full Text] [Related]
10. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model. Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303 [TBL] [Abstract][Full Text] [Related]
12. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection. Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820 [TBL] [Abstract][Full Text] [Related]
13. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax. Oscherwitz J; Feldman D; Yu F; Cease KB Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087 [TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax. Oscherwitz J; Yu F; Cease KB J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants. Berthold I; Pombo ML; Wagner L; Arciniega JL Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model. Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543 [TBL] [Abstract][Full Text] [Related]
19. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits. Ribot WJ; Powell BS; Ivins BE; Little SF; Johnson WM; Hoover TA; Norris SL; Adamovicz JJ; Friedlander AM; Andrews GP Vaccine; 2006 Apr; 24(17):3469-76. PubMed ID: 16519970 [TBL] [Abstract][Full Text] [Related]
20. Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores. Peachman KK; Li Q; Matyas GR; Shivachandra SB; Lovchik J; Lyons RC; Alving CR; Rao VB; Rao M Clin Vaccine Immunol; 2012 Jan; 19(1):11-6. PubMed ID: 22089245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]